Evidence map›Paper›PMID 33219445›Full record

SynthesisLasers in medical science2021

Photobiomodulation on trigeminal neuralgia: systematic review.

Ana Melissa Ccopa Ibarra, Daniela Aparecida Biasotto-Gonzalez, Edna Yoshiko Ide Kohatsu, Simone Saldanha Ignacio de Oliveira, Sandra Kalil Bussadori, João Paulo Colesanti Tanganeli

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Lasers in medical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ana Melissa Ccopa IbarraBiophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, Avenida Rua Vergueiro, 235/249-Liberdade, São Paulo, SP, 01504-001, Brazil. Ibarra.odonto@outlook.com.ORCID https://orcid.org/0000-0002-6855-1859
Daniela Aparecida Biasotto-GonzalezBiophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, Avenida Rua Vergueiro, 235/249-Liberdade, São Paulo, SP, 01504-001, Brazil.
Edna Yoshiko Ide KohatsuTMD and Orofacial Pain Clinical Department, Nove de Julho University - UNINOVE, São Paulo, SP, Brazil.
Simone Saldanha Ignacio de OliveiraDivision of Prosthodontics, Center of TMD and Orofacial Pain, School of Dentistry, Federal Fluminense University, Rio de Janeiro, Brazil.
Sandra Kalil BussadoriBiophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, Avenida Rua Vergueiro, 235/249-Liberdade, São Paulo, SP, 01504-001, Brazil.
João Paulo Colesanti TanganeliBiophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, Avenida Rua Vergueiro, 235/249-Liberdade, São Paulo, SP, 01504-001, Brazil.
Universidade Nove de Julho · BRUniversidade Federal Fluminense · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

Trigeminal neuralgia is a recurrent episode of facial pain, that may be associated with other conditions such as multiple sclerosis, neoplasms, and nerve compromises or may occur due to an unknown cause. The available treatments are pharmacotherapy or surgery; however, both are susceptible to develop side effects. Photobiomodulation could be a promising alternative therapy for trigeminal neuralgia. A systematic review of literature was carried out using the PRISMA protocol, in the PubMed/MEDLINE, Embase, and Web of Science databases. Risk of bias by ROB 2.0 protocol was performed in included studies. Initially, 20 identified articles were collected varying between the years of 1983-2018, from which 6 were included. A total of 193 patients were evaluated; photobiomodulation was compared to conventional therapies, TENS, and therapy combinations with pharmacotherapy. The overall risk of bias was low, with some concerns in the randomization and double-blinding process; moreover, there are few reports in the literature. Photobiomodulation appears to be as effective as conventional therapies, being a coadjutant therapeutic opportunity for the treatment of trigeminal neuralgia.

Indexed as

HumansLow-Level Light TherapyRandomized Controlled Trials as TopicTrigeminal NeuralgiaIdiopathic facial painLow-level laser therapyPhotobiomodulationTrigeminal neuralgia

Identifiers

PMID33219445
OpenAlexW3099480712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.